MDM2 and neoplasm: Additionally, the T to G allelic change introduced by mouse double minute 2 (MDM2) promoter SNP 309 was predicted to increase the affinity of the Sp1 transcription factor by extending the length of a Sp1 binding site, resulting in repressed tumor suppressor activity of the p53 pathway [4].